| Followers | 967 |
| Posts | 387456 |
| Boards Moderated | 0 |
| Alias Born | 06/24/2011 |
Tuesday, April 03, 2018 8:52:37 AM
.113 thin on the ask
BCTXF
BCTXF
Recent BCTX News
- BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models • GlobeNewswire Inc. • 04/21/2026 11:30:00 AM
- BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting • GlobeNewswire Inc. • 04/20/2026 11:30:00 AM
- BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License • GlobeNewswire Inc. • 03/31/2026 08:05:06 PM
- BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference • GlobeNewswire Inc. • 03/18/2026 11:30:00 AM
- BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting • GlobeNewswire Inc. • 03/10/2026 11:30:00 AM
- BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting • GlobeNewswire Inc. • 03/05/2026 09:04:34 PM
- BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License • GlobeNewswire Inc. • 02/18/2026 10:30:00 PM
- BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer • GlobeNewswire Inc. • 02/17/2026 12:30:00 PM
- BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation • GlobeNewswire Inc. • 01/28/2026 12:30:00 PM
- BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients • GlobeNewswire Inc. • 01/27/2026 12:30:00 PM
- BriaCell Therapeutics Announces Closing of US$30 million Public Offering • GlobeNewswire Inc. • 01/15/2026 09:05:00 PM
- BriaCell Therapeutics Shares Sink After $30 Million Capital Raise • IH Market News • 01/14/2026 03:18:54 PM
- BriaCell Therapeutics Announces Pricing of $30 million Public Offering • GlobeNewswire Inc. • 01/14/2026 02:00:22 AM
- BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient • GlobeNewswire Inc. • 01/13/2026 12:30:00 PM
- How $594B in Precision Tech is Cracking the Metastatic Cancer Code • PR Newswire (Canada) • 01/07/2026 03:32:00 PM
- How $594B in Precision Tech is Cracking the Metastatic Cancer Code • PR Newswire (US) • 01/07/2026 03:32:00 PM
- “Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine • GlobeNewswire Inc. • 12/18/2025 12:30:00 PM
- BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025 • GlobeNewswire Inc. • 12/10/2025 12:30:00 PM
- BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout • GlobeNewswire Inc. • 12/09/2025 12:30:00 PM
- BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025 • GlobeNewswire Inc. • 12/02/2025 12:30:00 PM
- BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025 • GlobeNewswire Inc. • 11/25/2025 12:30:00 PM
- BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics • GlobeNewswire Inc. • 11/20/2025 12:30:00 PM
- BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025 • GlobeNewswire Inc. • 11/18/2025 12:30:00 PM
- BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025 • GlobeNewswire Inc. • 11/07/2025 12:30:00 PM
- BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models • GlobeNewswire Inc. • 11/04/2025 12:30:00 PM
